SRPK1 and breast carcinoma: To date, only two studies have investigated the potential role of RBM4 in tumors: Lin et al. found that the SRPK1-RMB4 network may contribute to tumorigenesis through altered sensitivity to apoptotic signals in breast cancer cells23.